We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion

News   May 29, 2013

 
Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion
 
 
 

RELATED ARTICLES

The Power of Collaboration: Tackling Pharmaceutical Challenges

News

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

A Nice Reactive Ring to It

News

Researchers have introduced a new synthetic process for producing an important family of carbon-based molecules known as γ-aryl-β-ketoesters. These molecules are used in the production of many vital pharmaceuticals.

READ MORE

Building Biologically Active Compounds Using Light

News

Researchers have now published a new method for building 3D scaffolds from flat aromatics using a photocatalyst.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE